CARUSO JAMES V 4
4 · Cellectar Biosciences, Inc. · Filed Feb 4, 2020
Insider Transaction Report
Form 4
CARUSO JAMES V
DirectorPresident and CEO
Transactions
- Award
Common stock
2020-02-03$2.71/sh+100,000$271,000→ 100,000 total
Footnotes (1)
- [F1]Common stock grant that vests in equal annual increments on February 3, 2021, February 3, 2022, and February 3, 2023.